Cambridge researchers will play a key role in clinical trials of a new treatment that involves transplanting healthy nerve cells into the brains of patients with Parkinson’s disease.
Why are we getting so fat? Why do teenagers really need to lie-in? And can we fix a broken brain? These are just some of the questions that will be answered at Cambridge BRAINFest 2017, a free public festival celebrating the most complex organ in the body.
The Academy of Medical Sciences has announced the election of its new Fellows, including five Cambridge University academics.
Just one shot of dopamine cells derived from stem cells could be enough to reverse many of the features of Parkinson’s disease for decades – and the barriers to developing such a treatment are finally being overcome.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson’s and other neurodegenerative diseases.
Scientists and clinicians across Europe have joined forces to improve the efficacy and safety of neural transplantation in Parkinson’s disease.
© 2024 University of Cambridge